RhumbLine Advisers’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Buy |
40,685
+12,604
| +45% | +$121K | ﹤0.01% | 2838 |
|
|
2025
Q1 | $261K | Buy |
28,081
+1,879
| +7% | +$17.5K | ﹤0.01% | 2969 |
|
|
2024
Q4 | $364K | Buy |
26,202
+1,027
| +4% | +$14.3K | ﹤0.01% | 2872 |
|
|
2024
Q3 | $592K | Buy |
25,175
+1,603
| +7% | +$37.7K | ﹤0.01% | 2590 |
|
|
2024
Q2 | $377K | Buy |
23,572
+2,574
| +12% | +$41.2K | ﹤0.01% | 2854 |
|
|
2024
Q1 | $344K | Sell |
20,998
-334
| -2% | -$5.48K | ﹤0.01% | 2900 |
|
|
2023
Q4 | $295K | Sell |
21,332
-129
| -0.6% | -$1.79K | ﹤0.01% | 2983 |
|
|
2023
Q3 | $296K | Buy |
21,461
+176
| +0.8% | +$2.42K | ﹤0.01% | 2943 |
|
|
2023
Q2 | $362K | Sell |
21,285
-641
| -3% | -$10.9K | ﹤0.01% | 2889 |
|
|
2023
Q1 | $352K | Buy |
21,926
+1,178
| +6% | +$18.9K | ﹤0.01% | 2564 |
|
|
2022
Q4 | $158K | Buy |
20,748
+115
| +0.6% | +$876 | ﹤0.01% | 2841 |
|
|
2022
Q3 | $181K | Buy |
20,633
+3,348
| +19% | +$29.4K | ﹤0.01% | 2918 |
|
|
2022
Q2 | $124K | Buy |
17,285
+5,559
| +47% | +$39.9K | ﹤0.01% | 3014 |
|
|
2022
Q1 | $125K | Buy |
+11,726
| New | +$125K | ﹤0.01% | 2848 |
|